Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Weisnicht

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Hematopathology|December 9, 2025
From famine to feast: a seesawing platelet count in severe iron deficiency anemiaAllison Weisnicht, Eduard Matkovic
Journal of Pediatric Hematology/Oncology|April 6, 2026
Follicular Dendritic Cell Sarcoma in an Adolescent PatientHannah Glanz, Allison Weisnicht, Kristin Bradley, et al.
Pediatric Blood & Cancer|April 21, 2025
What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric MalignanciesZachary L Taylor, Tamara P Miller, Sarah G Board, et al.
Cancers|February 25, 2023
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well ToleratedAlexandra McLean Stevens, Eric S Schafer, Minhua Li, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Hematopathology|December 9, 2025
From famine to feast: a seesawing platelet count in severe iron deficiency anemiaAllison Weisnicht, Eduard Matkovic
Journal of Pediatric Hematology/Oncology|April 6, 2026
Follicular Dendritic Cell Sarcoma in an Adolescent PatientHannah Glanz, Allison Weisnicht, Kristin Bradley, et al.
Pediatric Blood & Cancer|April 21, 2025
What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric MalignanciesZachary L Taylor, Tamara P Miller, Sarah G Board, et al.
Cancers|February 25, 2023
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well ToleratedAlexandra McLean Stevens, Eric S Schafer, Minhua Li, et al.
Pageof 1